We have been informed that the current Methylphenidate Hydrochloride MR (the 12-hour Tablets) in all strengths are in very limited supply or currently unavailable
Examples of these are:
- Matoride
- Concerta XL
- Xaggitin XL
- Xenidate XL
- Delmosart
- Affenid
Again, disappointingly there appears to have been no warning about this in advance of the shortages, and also no communication from the relevant drug companies.
As you are aware multiple drug companies produce Methylphenidate Hydrochloride MR and so we are unsure of the exact reasons for this; however, as an alternative, there is current availability of Methylphenidate Hydrochloride Capsules, which are an 8 hourly preparation with no current shortages.
We have also directly confirmed this with the relevant Drug company representative.
As such if the shortages continue please do not hesitate to get in contact with us and we will aim to change your prescription to an available preparation.
It will likely be a capsule form (instead of a tablet), and also it may be that whilst shortages persist you may need 2 types of methylphenidate to ensure you have good daily treatment for your ADHD symptoms.
However, clinicians will ensure they review all records individually to find the best treatment plan for you.
Dr Georgina Brown
Clinical Governance Lead
ADHD Direct
ADHD Medications affected by the shortage
Methylphenidate:
• Equasym XL® 10, 20 and 30 mg capsules
• Xaggitin XL® 18 and 36 mg prolonged-release tablets
• Xenidate XL® 27 mg prolonged-release tablets
Lisdexamfetamine:
• Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules
• Elvanse® Adult 30, 50, and 70 mg capsules
Guanfacine:
• Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets
The shortages are due to the disruption of these products caused by a combination of manufacturing issues and increased global demand. You can find further details on the availability on the SPS website.
Expected stock availability:
Vyvanse® & Intuniv®:
Unlicensed imports of lisdexamfetamine (Vyvanse®) capsules and guanfacine (Intuniv®) prolonged-release tablets have been sourced.
Equasym XL®:
Limited parallel imports of methylphenidate (Equasym XL®) modified release capsules remain available.
Atomoxetine:
The supply issue with atomoxetine is set to be resolved in October 2023.
Subscribe here to receive emails with updates on the situation:
Next steps:
If your medication is currently affected by the shortage and you require a prescription, you have the following options:
-
Get the prescriptions sent directly to your home or pick it up in our clinic and contact local pharmacies. Some pharmacies might have stock left or restock small amounts.
-
Wait until your medication is back in stock.
Getting a new prescription
You can ask our team to email you a copy of your prescription prior to posting it. Some pharmacies require a copy of the prescription to reserve the medication.
Book a medication review
Book your medication review today. Medication reviews are available as virtual appointments and as in-person appointments in our clinic in Glasgow
